The prior two chapters discussed anti-platelet and anti-thrombin therapies for the treatment of ACS. Together they form the foundation for ACS management, especially during reperfusion therapy. However, other therapies, such as statins, beta-blockers and ACE inhibitors are also important. These therapies not only help to limit infarct size and reduce recurrent myocardial infarction, but also improve survival.
KeywordsPercutaneous Coronary Intervention Acute Coronary Syndrome Acute Myocardial Infarction Statin Therapy Recurrent Myocardial Infarction
Unable to display preview. Download preview PDF.
- 10.Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. Circulation 1998; 97:2202–2212.Google Scholar
- 14.Chen ZM, Pan HC, Chen YP, et al.; COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366:1622–1632.CrossRefGoogle Scholar
- 18.ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 1995; 345:669–685.CrossRefGoogle Scholar